Suss Microtec Se ((DE:SMHN)) has held its Q4 earnings call. Read on for the main highlights of the call.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Süss MicroTec SE delivered a mixed message in its latest earnings call. Management celebrated record 2025 revenue, strong late-year orders and strategic progress, but also warned that 2026 will be a transition year with lower sales and slimmer margins as the group absorbs relocation costs and leans into heavy R&D spending to secure future growth.
Record revenue marks a new scale milestone
Süss MicroTec crossed a symbolic threshold in 2025, reporting revenue of EUR 503.0 million for the first time above the EUR 0.5 billion mark. The top line has expanded by about EUR 200 million in just two years, from roughly EUR 300 million, underscoring a multi-year growth phase despite recent market softness.
Order momentum stabilizes with strong Q4 and Q1
Order intake for 2025 reached EUR 354.0 million, with a notably strong fourth quarter of EUR 117.5 million and a book‑to‑bill around 1. Management said that momentum has carried into the new year, with first‑quarter 2026 orders coming in even higher than the robust Q4 level, signaling stabilizing demand.
Advanced Backend and Photomask drive segment gains
Advanced Backend Solutions revenue rose about 10.7% to around EUR 350 million, while Photomask Solutions climbed 17.3% to above EUR 150 million. Within these segments, imaging and coating systems were standout performers, each posting year‑on‑year growth of more than 50% and highlighting strong demand for specialized tools.
Photomask margins show notable improvement
Photomask Solutions not only grew sales but also improved profitability, lifting gross margin by roughly 5 percentage points. The EBIT margin advanced by about 8 percentage points, helped by higher volumes, a better product and customer mix and a reduced backlog that allowed more efficient execution.
Taiwan Zhubei facility comes fully online
Operationally, a key milestone was the successful ramp‑up of the new production site in Zhubei, Taiwan, which is now fully operational. The first tool was produced there in February, about 10 tools were built in the first quarter of 2026, and management expects Q1 2026 to be the last quarter with a material P&L drag from the relocation.
Balance sheet strength and new syndicated loan
The company reported an equity increase of EUR 32.5 million, lifting the equity ratio to 62.2%, up 5.6 percentage points year on year. Liquidity was further bolstered by a new five‑year syndicated facility that lifts financial flexibility to EUR 115 million, combining an EUR 85 million revolving credit line with EUR 30 million in guarantees.
R&D spending underpins ambitious product roadmap
Management emphasized it will maintain or even increase R&D outlays despite softer near‑term revenue, seeing innovation as critical to future growth. The roadmap includes three new Photomask products and a panel‑capable EUV projection scanner planned for 2026, followed by a next‑generation wafer version targeted for 2027.
Cash generation turns positive in the final quarter
After a more challenging first half, cash generation improved toward year‑end, with the fourth quarter showing positive cash flow of EUR 5.6 million. Free cash flow from continuing operations was reported at roughly EUR 22.6 million, indicating that the core business remains capable of funding itself even amid transition costs.
2026 guidance points to revenue and margin decline
Management framed 2026 as a transition year with sales expected between EUR 425 million and EUR 485 million, implying a mid‑single‑digit to low double‑digit decline from 2025 at the midpoint. EBIT margin is guided down to 8–10% from 13.1% in 2025, with a broadly stable gross margin of 35–37% as the company prioritizes R&D and absorbs lower volumes.
Profitability squeezed in second half of 2025
For 2025 overall, Süss MicroTec posted a gross margin of 35.7% and an EBIT margin of 13.1%, but management acknowledged a clear profitability dip in the second half. The pressure stemmed from weaker earlier order intake, an unfavorable product and customer mix, ramp‑up support costs and one‑off expenses tied to the Taiwan move.
Net profit and cash step down from prior year
Net profit fell to EUR 46.1 million in 2025, down sharply from EUR 110 million a year earlier, though the 2024 result was flattered by a one‑time MicroOptics divestment gain. Cash and cash equivalents stood at EUR 98.7 million, down by around EUR 33.5–37.5 million year on year, leaving net cash at EUR 49.1 million after leasing liabilities.
Operating expenses rise on R&D and digitalization
Operating costs moved higher as the group invested in future capabilities, with selling, administrative and R&D expenses rising from roughly EUR 100 million to EUR 118 million. The EUR 18 million increase was driven by about EUR 7 million more in R&D, spending on IT, digitalization and ERP measures and the full‑year impact of previous hiring.
Photomask orders and China exposure weigh on intake
Order intake in Photomask Solutions dropped to around EUR 80 million, a decline of EUR 43.5 million year on year that was heavily linked to China. Management attributed about EUR 31 million of the shortfall to lower demand from Chinese customers, and also flagged that weaker prepayments from China hurt liquidity in 2025.
Taiwan relocation brings one‑off and transition costs
The move from the old Hsinchu site to Zhubei did not come for free, with double rent during the overlap period and write‑offs for old clean‑room equipment weighing on results. The new lease structure created a roughly EUR 40 million right‑of‑use liability, and management expects some remaining double‑cost effects in the low single‑digit million range near term.
Near‑term margins exposed to volume and mix swings
While the company aims to hold gross margins broadly steady within its guided range, management cautioned that margins could be volatile. Lower volumes in 2026 and shifts in product and customer mix may limit fixed‑cost absorption, and executives only expect meaningful structural margin improvement to emerge gradually from 2027 onward.
Guidance frames 2026 as a consolidation year
The forward‑looking message is that 2026 will be about consolidation and preparation rather than headline growth, with both Advanced Backend and Photomask Solutions expected to see sales decline by roughly 10%. Still, Süss MicroTec enters this period with an opening order book of EUR 266.8 million, a 2025 book‑to‑bill at about 1, strong early‑2026 orders and sizable balance‑sheet buffers including cash, net cash and the new syndicated facility.
Süss MicroTec’s earnings call painted a company at an inflection point, balancing record scale and solid segment momentum against softer demand, especially from China, and a deliberate hit to margins in 2026. For investors, the story now hinges on whether sustained R&D spending and the new Taiwan platform can convert this transition year into higher growth and stronger margins from 2027 onward.